About Us
   Programs
   Results
   Mission/Vision
   Leadership

Support Us

Research Awards
   About
   Impact
   Award Recipients
   Apply for an Award

Collaboration
   Clinical Network
   Preclinical Screening
   Industry

News Room
   What's New
   Advance Newsletter
   Releases
   In the News
   Media Kit

Resources/Information
   Learn from the Experts
   Statistics
   Clinical Trials
   Additional Resources

Contact Us

Home

Preclinical Screening Program

In 2002, Accelerate Brain Cancer Cure and the Preston Robert Tisch Brain Tumor Center at Duke University formed the Preclinical Screening Program, a groundbreaking collaboration that establishes a critical missing link between the biopharmaceutical industry's efforts to produce potentially life-saving drugs and the theoretical knowledge at the cutting edge of scientific inquiry. Funding allows researchers from any sector - academia, industry, and government - to submit compounds that hold the potential to benefit brain cancer research to Duke for screening, free of charge.

This program encourages researchers, corporations, and federal agencies to test both approved and experimental therapies that target other types of cancers for their potential benefit to brain cancer patients. This program is run by an active Executive Committee managed by Accelerate Brain Cancer Cure.

How it Works
Accelerate Brain Cancer Cure and Duke consider requests from drug sponsors for preclinical evaluation. If there is agreement to test the potential therapies, a Material Transfer Agreement (MTA) is created. Once the MTA is signed, testing is initiated. Jointly, Accelerate Brain Cancer Cure and Duke are focused on accountability and maintain frequent interaction during all potential therapy testing.

Impact
To date, more than 150 compounds have been tested or are in under consideration for this program. The researchers at Duke have initiated trials for 18 therapies in brain tumor patients on the basis of results obtained through the Duke Preclinical Testing Program.

Content copyright © 2008 Accelerate Brain Cancer Cure, Inc.